Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Total Centella Triterpenes is a standardized botanical extract derived from *Centella asiatica* (Gotu kola), developed and manufactured by Guangxi Changzhou Natural Pharmaceutical. The extract contains a mixture of pentacyclic triterpenes, primarily asiaticoside, madecassoside, asiatic acid, and madecassic acid. These compounds are known for their pharmacological activities, including promoting collagen synthesis, enhancing wound healing, and providing anti-inflammatory and antioxidant effects. It is utilized as a pharmaceutical raw material and active ingredient in topical treatments for skin repair, scars, and venous insufficiency, as well as in cosmetic and nutraceutical formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on total centella triterpenes.